Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways

  • Edward M. Rosser
  • , Simon Morton
  • , Kate S. Ashton
  • , Philip Cohen
  • , Alison N. Hulme

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The synthesis of C(4)H and C(4)Me analogues of the JNK/p38 pathway activator anisomycin, based upon an aldol or Claisen construction of the C(3)-C(4) bond, has been demonstrated. The relative activation of the JNK/SAPK1 and p38/SAPK2 pathways in RAW macrophages by these analogues, and their synthetic precursors, has been assessed using immunoblot assays against phosphorylated c-Jun and MAPKAP-K2. These studies demonstrate that some of the synthetic C(4) analogues are also potent activators of these stress kinase pathways.

Original languageEnglish
Pages (from-to)142-149
Number of pages8
JournalOrganic and Biomolecular Chemistry
Volume2
Issue number1
DOIs
StatePublished - 7 Jan 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways'. Together they form a unique fingerprint.

Cite this